27.14
-1.49%
Close of 9 Nov 2026, in INR
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About Sigachi Industries
Its shares trade on NSE under the ticker SIGACHI.NS. It has been listed since 15 November 2021. In the fiscal year to 31 March 2026, it reported revenue of ₹4.78bn and a net loss of ₹817.6m. At that date it held total assets of ₹8.41bn and shareholders' equity of ₹5.22bn.
Sigachi Industries Ltd is a IN-based company operating in Pharmaceuticals industry. The company is headquartered in Hyderabad, Telangana. The company went IPO on 2021-11-15. Sigachi Industries Limited is an India-based company that manufactures primarily microcrystalline cellulose (MCC). The firm is engaged in manufacturing cellulose-based excipients for finished dosages in the pharmaceutical industry. The Company’s products include EXCiPACT GMP, SGMP, HACCP and EDQM CEP. The firm's pre-formulated excipients include BARETab PH, BARETab ODT and BARETab Nutra. The company produces MCC in various grades ranging from 15 to 250 microns for the domestic and export markets under the HiCel and AceCel brands. The firm offers Anti-ulcers (Gastrointestinal) Products and their Intermediates. The company operates over three manufacturing units situated in Hyderabad, Jhagadia and Dahej. The firm serves pharmaceutical, food and nutraceuticals, cosmetic and chemical industries. Its international business spreads across 50 countries, including Asia, Australia, American Continent, Europe and the Middle East.
Figures and description from our data supplier, not checked against the company's own report.
Company facts
- Sector
- Health Care
- Industry
- Pharmaceuticals
- Listed since
- 15 Nov 2021
- Employees
- 1,034
- Website
- sigachi.com ↗
Leadership
Pay as last reported
- Mr. Rabindra SinhaWhole Time Chairman of the Board, since 2019₹14.5m
- Mr. Amit SinhaChief Executive Officer, Managing Director, since 2006₹17.1m
- Mr. Chidambarnathan ShanmuganathanWhole Time Vice Chairman of the Board, since 2019₹14.5m
- Mr. Subbarami ReddyChief Financial Officer
- Mr. Vivek KumarCompliance Officer, Company Secretary
- Ms. Bindu VinodhanIndependent Director
- Ms. Dhanalakshmi GuntakaNon-Executive Independent Director₹270,000
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 0
- Environment
- 0
- Social
- 0
- Governance
- 0
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- Sigachi Industries Ltd manufactures microcrystalline cellulose (MCC) in 15 to 250 micron grades for domestic and export markets.
- The company produces EXCiPACT GMP, SGMP, HACCP, and EDQM CEP certified excipients for pharmaceuticals.
- Sigachi operates three manufacturing units in Hyderabad, Jhagadia, and Dahej serving global markets.
Weaknesses
- Sigachi Industries Ltd has 1,034 employees and operates in the Health Care sector.
- The company's products include Anti-ulcers (Gastrointestinal) Products and their Intermediates.
- Sigachi Industries Limited serves pharmaceutical, food, nutraceuticals, cosmetic, and chemical industries.
Opportunities
- Sigachi Industries Ltd exports to 50 countries across Asia, Australia, America, Europe, and the Middle East.
- The firm's pre-formulated excipients BARETab PH, ODT, and Nutra target growing nutraceutical markets.
- Sigachi's HiCel and AceCel brands cover MCC grades for domestic and export pharmaceutical needs.
Threats
- Sigachi Industries Ltd faces competition in the global pharmaceutical excipients market.
- The company's manufacturing units in Hyderabad, Jhagadia, and Dahej could face supply chain disruptions.
- Sigachi's reliance on MCC production may limit diversification in the Health Care sector.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.